Detection of Structural Variants in Circulating Cell-Free DNA from Sarcoma Patients Using Next Generation Sequencing

Detection of Structural Variants in Circulating Cell-Free DNA from Sarcoma Patients Using Next Generation Sequencing

Circulating tumour DNA (ctDNA) analysis using next generation sequencing (NGS) is being implemented in clinical practice for treatment stratification and disease monitoring. However, using ctDNA to detect structural variants, a common occurrence in sarcoma, can be challenging. Here, we use a sarcoma...

Full description

Bibliographic Details
Main Authors: Lauren Mc Connell, Jana Gazdova, Katja Beck, Shambhavi Srivastava, Louise Harewood, JP Stewart, Daniel Hübschmann, Albrecht Stenzinger, Hanno Glimm, Christoph E. Heilig, Stefan Fröhling, David Gonzalez
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
next generation sequencing
sarcoma
cell-free DNA
translocations
Online Access:https://www.mdpi.com/2072-6694/12/12/3627

Internet

https://www.mdpi.com/2072-6694/12/12/3627

Similar Items